Public health: Stronger rules on medical devices

27 May 2021 02:10 PM

As of yesterday, new EU rules on medical devices (MDR) enter into application, establishing a modern and more robust regulatory framework to protect public health and patient safety. The new rules start applying after a one-year postponement due to the unprecedented challenges of the coronavirus pandemic, addressing the need for an increased availability of vitally important medical devices across the EU.

The Regulation covers medical devices ranging from hip replacements to sticking plasters. It increases transparency and brings EU legislation in line with technological advances and progress in medical science. It improves clinical safety and creates fair market access for manufacturers.

Stella Kyriakides, Commissioner for Health and Food Safety, yesterday said:

“This is an important step forward for the protection of patients across Europe. The new rules improve the safety and quality of medical devices while providing more transparency for patients and less administrative burden for businesses. The legislation will strengthen innovation and our international competitiveness, ensuring that we are ready for any new and emerging challenges.”

In summary, the Medical Devices Regulation:

• Improves the quality, safety and reliability of medical devices: it imposes tighter controls on high-risk devices such as implants and requires the consultation of a pool of EU level experts before placing medical devices on the market. Clinical evaluations, investigations and the notified bodies that approve the certification of medical devices will be subject to tighter controls.
• Strengthens transparency and information for patients, so that vital information is easy to find. The European database of medical devices (EUDAMED), will contain information about each medical device on the market, including economic operators and certificates issued by notified bodies. Each device will have a unique device identifier so that it can be found in EUDAMED. More detailed labelling and electronic manuals will increase user-friendliness. Implant patients will receive an implant card with all the essential information.
• Enhances vigilance and market surveillance: Once devices are available on the market, manufacturers have to collect data about the devices' performance. EU countries will closely coordinate their vigilance and market surveillance.

Click here for the full press release